真菌的治療

治療藥物

  1. 表皮性黴菌、表淺性黴菌病
    • 角質溶解劑:salicylic acidthiosulfate
    • 局部抗黴菌藥:miconazole nitrate
    • 廣泛性感染時,可以使用griseofulvin + miconazole (2%)
  2. 下表皮黴菌病(subcutaneous mycoses)
    • SporotrichosisAmphotericin B
    • Mycetoma:細菌引起的可以用磺胺類藥物

 

念珠菌菌血症(candidemia)的治療
※強烈建議移除所有靜脈內管路!
沒有嗜中性球低下(candidemia in non-neutropenic patients)

  1. Empiric therapy
    • Mild illness without recent azole exposure: Fluconazole
    • Moderate to severe illness or recent azole exposure: Amphotericin B deoxycholate, Micafungin (Micafungin may reserve for poor renal function or can’t tolerance Amphotericin B deoxycholate.)
    • Alternative use:
      1. Caspofungin
      2. Voriconazole- step-down oral therapy for selected cases of candidiasis due to Candida krusei or Voriconazole-susceptible C. glabrata.
  2. Definitive use
    • C. albicans or C. tropicalis: Fluconazole
    • C. parapsilosis:
      1. Drug of choice: Fluconazole
      2. Alternative use: Amphotericin B deoxycholate or Voriconazole
      3. For patients who have initially received one therapy and are clinically improved, and whose follow-up culture results are negative, continuing use of this therapy is reasonable.
    • C. glabrata:
      1. Drug of choice: Micafungin
      2. Alternative use: Amphotericin B deoxycholate or Caspofungin
      3. For patients who have initially received one therapy and are clinically improved, and whose follow-up culture results are negative, continuing use of this therapy is reasonable.
    • C. krusei:
      1. Drug of choice: Micafungin
      2. Alternative use: Amphotericin B deoxycholate, Variconazole or Caspofungin

合併嗜中性球低下(candidemia in neutropenic patients)

  1. Empiric therapy
    • Drug of choice: Amphotericin B deoxycholate or Caspofungin
    • Alternative: Voriconazole or Micafungin or Itraconazole
  2. Definitive use
    • C. tropicalis or other culture: continue current therapy
    • For patients who have initially received one therapy and are clinically improved, and whose follow-up culture results are negative, continuing use of this therapy is reasonable.
    • C. parapsilosis:
      1. Drug of choice: Fluconazole
      2. Alternative use: Amphotericin B deoxycholate or Voriconazole
    • C. glabrata:
      1. Drug of choice: Micafungin
      2. Alternative use: Amphotericin B deoxycholate or Caspofungin
    • C. krusei:
      1. Drug of choice: Micafungin
      2. Alternative use: Amphotericin B deoxycholate, Variconazole or Caspofungin

 

※請依照病人臨床表現與症狀進行藥物選擇與劑量等調整

Duration of therapy for candidemia without obvious metastatic complications is for 2 weeks after documented clearance of candida from the bloodstream and resolution of symptoms attributable to candidemia.

Class

Medication (Generic (Brand))

Usual dosage

Polyenes

Amphotericin B deoxycholate 50mg/vial

0.5~1mg/kg QD

CCr < 10mL/min: usual IV dose (20 to 50mg) every 24~36 hours
Hemodialysis: no specific dose adjustments necessary

Azoles

Fluconazole (Diflucan) 100mg/bot

800mg (12mg/kg) load
400mg (6mg/kg) QD

Fluconazole (Diflucan) 50mg/cap

Usual loading then adjust daily doses as follow:
CCr < 50mL/min: administer 50% of recommended dose
Hemodialysis: 100% of the usual dose after each hemodialysis session or 200mg (3mg/kg) QD

Voriconazole (Vfend) 200mg/vial

400mg (6mg/kg) Q12H for 2 doses for loading then 200mg (3mg/kg) Q12H

Voriconazole (Vfend) 200mg/tab

Maintenance dose:
Patients <40kg: 100mg Q12H
Maximum: 300mg/day
Patients >40kg: 200mg Q12H
Maximum: 600mg/day

CCr < 50mL/min: oral formulation is preferred over IV to prevent accumulation of IV vehicle
Hepatic cirrhosis:
-IV: 6mg/kg Q12H for 2 doses, then 2mg/kg Q12H
-Oral: patients < 40kg: 50mg Q12H, > 40kg: 100mg Q12H

Echinocadins

Caspofungin (Cancidas) 50mg/vial

70mg load, then 50mg QD

Renal impairment: no dosage adjustment necessary
Hepatic impairment: moderate impairment (Child-Pugh score 7~9):
70mg IV loading dose should be given on day 1, then 35mg IV QD

Micafungin (Mycamine) 50mg/vial

100mg QD

Anidulafungin (Eraxis) 100mg/vial

200mg load, then 100mg QD

~~~No dosage adjustment~~~

 

預防性抗真菌藥物使用(prophylaxis)

  1. Solid-organ transplant recipients
    • Fluconazole 400mg QD or
    • LFAmB (lipid formulation of amphotericin B) 1~2mg/kg QD for 7~14 days
  2. Patient hospitalize in the ICU
    • Fluconazole 400mg QD is recommended.
  3. Patient with chemotherapy induced neutropenia
    • Fluconazole 400mg QD or
    • Posaconazole 200mg TID or
    • Caspofungin 50mg QD
    • Oral Itraconazole 200mg BID is an effective alternative.
  4. Stem cell transplant recipients with neutropenia
    • Fluconazole 400mg QD or
    • Posaconazole 200mg TID or
    • Micafungin 50mg QD

 

抗真菌機轉及其對應的藥物

  1. 抑制DNARNA合成
    • Ciclopirox (iron-dependent mitochondrial enzyme結合)
    • Flucytosine
  2. DNA結合
    • Metronidazole
  3. RNA結合
    • Griseofulvin
  4. 抑制細胞壁的合成Echinocandin
    • Caspofungin
    • Micafungin
    • Anidulafungin
  5. 抑制c14-alpha-demethylase
    • Ketoconazole
    • Itraconazole
    • Fluconazole
    • Miconazole
    • Posaconazole
    • Voriconazole
    • Butoconazole Nitrate
    • Clotrimazole
    • Econazole
    • Oxiconazole
    • Sertaconazole Nitrate
    • Sulconazole
    • Tioconazole
    • Terconazole
  6. 與細胞膜結合,破壞完整性
    • Natamycin
  7. ergosterol結合
    • Amphotercin B
    • Nnystatin
  8. 抑制squalene epoxidase
    • Terbinafine
  9. 破壞細胞膜結構
    • Tolnaftate
    • Tolciclate
  10. 抑制delta-7,8 reductase
    • Amorolfine

 

antifungal_medication.PNG


arrow
arrow
    創作者介紹
    創作者 TeachingCenter. 的頭像
    TeachingCenter.

    ~Teachingcenter的醫學筆記~

    TeachingCenter. 發表在 痞客邦 留言(0) 人氣()